Duvelisib

duvelisib · Secura Bio, Inc.

Drug timelines are a Plus or Pro feature.

29 regulatory and trial events tracked for Duvelisib, covering 2016-07-26 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome [Phase 1]